Strategizing a new drug launch? Don’t overlook soft skills for sales reps, whitepaper says
When launching a new drug, pharma companies often focus on tangible targets like awareness, message recall or number of sales rep interactions and time spent with physicians. However, when it comes to prescribing a new drug, healthcare providers (HCPs) are more likely to do so if they trust the sales rep and if the message delivered is clear and unique, according to a recent HCP survey and whitepaper from ZoomRx.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
